Domain Partners
Venture capitalPrinceton · 5 people tracked
Find your way into Domain Partners
Fund manager profile
Domain Partners is a venture fund manager based in Princeton. SEC filings show 1 venture fund on record, most recently Domain Partners IX, L.P. filed December 2016.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 5 people
from public directoriesWhat they invest in
from 6 of 7 portfolio companiesBiotech ×5Healthtech ×5Medical Devices ×2AI & Machine Learning ×1
HQs:United States×7
Investments · 7 tracked
founders shown can be your intro pathBy year:2021 · 12017 · 22016 · 32015 · 17 dated
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease.
BiotechHealthtechMedical DevicesSan Diego, US
Paul Schimmel(Non-Management Director)John D. Mendlein(Executive Officer, Director)David Weiner(Executive Officer)Frederic Chereau(Executive Officer)
BoardAmir Nashat(Non-Management Director)inAkkaraju Srinivas(Non-Management Director)
Board seatJames C. Blair· per SEC Form D · $76.3M raise · filed Apr 2015
Co-investorsCardinal PartnersEcoR1 CapitalSofinnova VenturesPolaris PartnersSamsara BioCapitalViking Global Investors
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Paul Flook(Executive Officer, Director)inGregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)inAxel Scherer(Director)
BoardJustin Klein(Director)in
Board seatJames C. Blair· per SEC Form D · $12.1M raise · filed Apr 2017
Co-investorsAdjuvant CapitalGlobal BrainMoore Venture PartnersNew Enterprise Associates (NEA)Windham Capital PartnersDomain Associates+2 more
Currax Pharmaceuticals develops and markets a portfolio of therapies for chronic progressive diseases.
BiotechHealthtechLa Jolla, US
Preston Klassen(Executive Officer)inJoseph Hagan(Executive Officer)Michael Narachi(Executive Officer, Director)Thomas Cannell(Executive Officer)
BoardEckard Weber(Director)
Board seatBrian H. Dovey· per SEC Form D · $49.6M raise · filed Mar 2017
Co-investorsCross Creek AdvisorsNew Enterprise Associates (NEA)Sofinnova VenturesDomain Associates
Antios Therapeutics develops antiviral therapies for hepatitis B virus (HBV) and other viral diseases, including its Active Site Polymerase Inhibitor Nucleotide (ASPIN) ATI-2173 and a capsid assembly modulator program.
BiotechHealthtechMendham, US
Gregory Mayes(Executive Officer, Director)Douglas Mayers(Executive Officer)inTamra Adams(Executive Officer)inAbel De La Rosa(Director)
BoardIyona Rajkomar(Director)inBenjamin Rovinski(Director)
Co-investorsAisling CapitalAltium CapitalAvego BioScience CapitalPontifax Venture CapitalAmzak HealthDelos Capital+8 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 IPOsaTYR PHARMANASDAQ: ATYR
Fund performance · per public LP disclosures · 2
as of Jun 2020| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Domain Partners VII, L.P.LPs: The Regents of the University of California | 2006 | — | -1.4% | 0.95x | 0.95x |
| Domain Partners VI, L.P.LPs: The Regents of the University of California | 2003 | — | -4.8% | 0.81x | 0.81x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- How many investments has Domain Partners made?
- Domain Partners has 7 tracked investments, 1 of which have exited.
- Where is Domain Partners located?
- Domain Partners is headquartered in Princeton, US.